Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26M Buy
3,489
+184
+6% +$63K 0.1% 170
2026
Q1
$1.16M Buy
3,305
+1,168
+55% +$416K 0.11% 155
2025
Q4
$700K Buy
+2,137
New +$678K 0.07% 223
2025
Q2
Sell
-645
Closed -$201K 212
2025
Q1
$201K Buy
+645
New +$190K 0.06% 189

Other funds holding AMGN

Sentinus LLC's AMGN Position: Q2 2026 in Review

Sentinus LLC increased its Amgen (AMGN) stake by 5.6% in Q2 2026, buying an estimated $63K and bringing the position to 3,489 shares worth $1.26M. The position accounts for 0.1% of the portfolio, ranked #170.

Sentinus LLC first reported a position in AMGN in Q1 2025 and has held it in 4 quarters since. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sentinus LLC held 3,489 shares of Amgen worth $1.26M as of Q2 2026.
  • Sentinus LLC bought 184 Amgen shares in Q2 2026, an estimated $63K.
  • Amgen made up 0.1% of Sentinus LLC's portfolio in Q2 2026, its #170 holding.
  • Sentinus LLC first reported a position in Amgen in Q1 2025 and has held it in 4 quarters since.
  • 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sentinus LLC's 13F filing for Q2 2026, filed 11 Aug 2026.